Literature DB >> 6848743

Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat.

T C Westfall, L Naes, C Paul.   

Abstract

The effect of six dopamine agonists including apomorphine, epinine, dopamine, piribedil, lergotrile and bromocriptine on the incorporation of [3H]tyrosine into dopamine was studied in slices and synaptosomes prepared from various brain areas containing dopamine terminals including striatum, nucleus accumbens, olfactory tubercle and medial basal hypothalamus. It was observed that all of these drugs were active in causing a decrease in dopamine synthesis in these various brain areas. The catecholamine agonists apomorphine, epinine and dopamine were more potent in inhibiting dopamine synthesis in the mesolimbic structures than in the striatum. On the other hand, apomorphine and epinine were less potent while dopamine was more potent in the medial basal hypothalamus. The ergoline drugs were weak agonists in all structures studied. It is concluded that autoreceptor regulation of dopamine synthesis is more active in the mesolimbic compared with the nigrostriatal dopamine pathway while autoreceptors may be absent in the median eminence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848743

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats.

Authors:  R Pagliari; L Peyrin; O Crambes
Journal:  J Neural Transm Gen Sect       Date:  1995

2.  The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?

Authors:  A G Vulto; C J Fowler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

3.  Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Endogenous dopamine release from tuberoinfundibular neurons: does calmodulin play any role?

Authors:  G F Di Renzo; S Amoroso; M Taglialatela; L Annunziato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

5.  Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.

Authors:  G Laschinski; B Kittner; M Bräutigam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

6.  Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.

Authors:  F M Scalzo; L P Spear
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Effects of D2-dopaminergic receptor stimulation on male rat sexual behavior.

Authors:  M M Foreman; J L Hall
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.

Authors:  A C Barton; K E Moore; K T Demarest
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.